{"id":"W2267348707","doi":"10.1016/s0140-6736(15)01314-8","title":"Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial","year":2016,"lang":"en","type":"article","venue":"The Lancet","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":449,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Institute for Health and Care Research","keywords":"Fingolimod; Placebo; Medicine; Multiple sclerosis; Double blind; Internal medicine; Physical therapy; Alternative medicine; Pathology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001663354,0.002153427,0.004607763,0.000535013,0.0004749781,0.00119095,0.001012938,0.002721353,0.007693528],"category_scores_gemma":[0.001540371,0.0007350575,0.002678196,0.0005313823,0.001312146,0.001294011,0.0003901887,0.003108609,0.001435309],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006899616,"about_ca_system_score_gemma":0.001005338,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009325143,"about_ca_topic_score_gemma":0.002294009,"domain_scores_codex":[0.9995806,0.0001675651,0.00003553416,0.00007936948,0.00005012047,0.00008682186],"domain_scores_gemma":[0.9994684,0.000176764,0.0001307154,0.00003888655,0.00004111373,0.0001441198],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9757967,0.00182263,0.0002044812,0.001853227,0.001297246,0.00005821975,0.00004385506,0.0002223983,0.002335796,0.0001586343,0.001328769,0.01487803],"study_design_scores_gemma":[0.9858439,0.01235196,0.0005079073,0.00004318546,0.0004100123,0.00002551453,0.00001204014,0.0001088732,0.0001344927,0.0000933362,0.0004592152,0.000009534448],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9452356,0.033424,0.001894869,0.002568966,0.002548374,0.00578912,0.00293701,0.0006236341,0.00497841],"genre_scores_gemma":[0.9484522,0.0214193,0.004003406,0.004760832,0.001942862,0.00691848,0.002974395,0.00007875265,0.00944976],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007693528,"threshold_uncertainty_score":0.0257374,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04921788488952172,"score_gpt":0.2942073420759977,"score_spread":0.244989457186476,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}